Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
May 15, 2019 Off

Aphena Pharma Solutions Approves $7M for Expansion by End of Year

By BusinessWire

COOKEVILLE, Tenn.–(BUSINESS WIRE)–Aphena Pharma Solutions Inc. today announced that it has approved $7 million for company-wide expansion for future growth…

May 15, 2019 Off

Millendo Therapeutics Reports First Quarter 2019 Operating and Financial Results

By BusinessWire

– Initiated pivotal study of livoletide in Prader-Willi syndrome (PWS) – – Established foundation for a commercial organization in Boston…

May 15, 2019 Off

Landos Biopharma Announces Publication of Results from First-in-Human Phase 1 Study of BT-11 in Healthy Volunteers

By BusinessWire

BLACKSBURG, Va.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Crohns?src=hash" target="_blank"gt;#Crohnslt;/agt;–Landos Biopharma, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class, oral…

May 15, 2019 Off

LifeArc and GVK BIO Celebrate a Decade of Partnership, Transforming Research into Life-Saving Medicines

By BusinessWire

HYDERABAD, India & LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRDO?src=hash" target="_blank"gt;#CRDOlt;/agt;–GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one…

May 15, 2019 Off

Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis

By BusinessWire

Study achieves all co-primary and secondary endpoints NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a…

May 15, 2019 Off

PatientFi® Announces Study Partnership with Allergan

By BusinessWire

Commercial Study Will Measure Impact of Increasing Access and Affordability of Aesthetic Procedures IRVINE, Calif.–(BUSINESS WIRE)–PatientFi, LLC, a leading financial…

May 15, 2019 Off

Bijan Nejadnik, M.D., Appointed as Chief Medical Officer of SanBio

By BusinessWire

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.)(TOKYO:4592), a scientific leader in regenerative medicine for neurological…

May 15, 2019 Off

The Merck Healthcare Business to Keynote Veeva R&D Summit Europe

By BusinessWire

More than 500 life sciences professionals and industry experts to showcase advances for speeding product development BARCELONA, Spain–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/lifesciences?src=hash"…

May 15, 2019 Off

Dr. Reddy’s Laboratories announces the launch of Daptomycin for Injection, 500mg/vial single-dose vial in the U.S. Market

By BusinessWire

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…

May 15, 2019 Off

Sensorion Announces the Positive Data Safety Monitoring Board (DSMB) Review and Continuation of the Phase 2 Clinical Trial for SENS-111 in Acute Unilateral Vestibulopathy (AUV)

By BusinessWire

86 patients enrolled in SENS-111 clinical trial MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biopharmaceutical…

Posts pagination

Previous 1 … 5,799 5,800 5,801 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine